Skip to main content
Caplight Logo









Ybrain

Ybrain

Private
South KoreaHealthcare & Life Scienceshttps://www.ybrain.com/

Last Round

Growth Equity

Feb 23, 2022

Total Funding Raised

$24.24M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ybrain is a healthtech company that manufactures a wearable medical device intended to measure and treat neuropsychiatric illnesses based on neuroscience.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

wearable neuromodulationelectroceuticalstDCSDTxdepression treatmentdigital therapeuticsneurotechmental health techtranscranial direct current stimulationwireless EEGat-home treatmentremote patient monitoringnon-pharmacological treatmentmigraine reliefbrain-computer interfaceBCIAlzheimer's treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ybrain Comparables

Compare Ybrain with similar companies based on industry and business-model similarity.

Ybrain comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuroelectrics
83%
Flow Neuroscience
82%
Sooma
82%

Ybrain Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityFeb 23, 2022
Series CFeb 17, 2020
Series BNov 29, 2017
Series AAug 28, 2014
SeedFeb 1, 2013

Key People

Founding team and executive leadership

Kiwon Lee

CEO And CTO

Executive Team

권형준

부사장 CFO

Executive Team

Ybrain Investors

Notable investors and investment history

Ybrain investors
InvestorRounds
InterVestGrowth Equity
Company K Partners, LimitedSeries A
KDB Capital CorpSeries B
DSC InvestmentSeries A
KT&GGrowth Equity
G.N.Tech Venture CapitalSeries C
DTN VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 42% MoM.

  • Jun 19, 2026

    Monthly visitors increased 81% MoM, reaching 21K.

Ybrain Filings

Explore SEC and related filing metadata, where available.

Ybrain filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ybrain's valuation, stock price, and market status.

Is Ybrain a public or private company?

Ybrain is a private company.

What is the current stock price of Ybrain?

Ybrain is a private company with no public stock price. No recent secondary market data is available.

How much is Ybrain worth (valuation)?

Valuation information for Ybrain is not publicly available.

Can I buy Ybrain stock?

Ybrain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ybrain's last funding round?

Ybrain's most recent funding round was Growth Equity on February 23, 2022.

Who are the main investors in Ybrain?

Key investors in Ybrain include Stonebridge Capital.

Will Ybrain IPO soon?

No public IPO plans have been announced for Ybrain.

How can I track Ybrain secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ybrain's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Employee Range31
Year Founded2013
Last FundingFeb 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?